Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online

Anti-CDKN2A/p14ARF 抗体 [ARF 4C6/4] (ab11048)

Submit a review Q&A (5)References (6)
Immunocytochemistry/ Immunofluorescence - Anti-CDKN2A/p14ARF antibody [ARF 4C6/4] (ab11048)
  • Flow Cytometry - Anti-CDKN2A/p14ARF antibody [ARF 4C6/4] (ab11048)

Key features and details

  • Mouse monoclonal [ARF 4C6/4] to CDKN2A/p14ARF
  • Suitable for: Flow Cyt, ICC/IF
  • Reacts with: Human
  • Isotype: IgG2a

リコンビナント抗体で、ロット間での高い再現性を実現

Product image
Anti-CDKN2A/p14ARF antibody [SP271] (ab216602)
  • 異なるロット間での安定した再現性
  • 容易なスケールアップ
  • 評価試験による特異性の確認済み
  • 倫理基準に準拠 - アニマル・フリーの生産

製品の概要

  • 製品名

    Anti-CDKN2A/p14ARF antibody [ARF 4C6/4]
    CDKN2A/p14ARF 一次抗体 製品一覧

  • 製品の詳細

    Mouse monoclonal [ARF 4C6/4] to CDKN2A/p14ARF

  • 由来種

    Mouse

  • アプリケーション

    適用あり: Flow Cyt, ICC/IFmore details

  • 種交差性

    交差種: Human

  • 免疫原

    Tissue, cells or virus corresponding to Bacteria CDKN2A/p14ARF.

  • 特記事項

    The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.

    If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As

製品の特性

アプリケーション

The Abpromise guarantee

Abpromise保証は、 次のテスト済みアプリケーションにおけるab11048の使用に適用されます

アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。

アプリケーション Abreviews 特記事項
Flow Cyt
Use 0.5µg for 106 cells.

ab170191 - Mouse monoclonal IgG2a, is suitable for use as an isotype control with this antibody.

 
ICC/IF
Use at an assay dependent concentration.
特記事項
Flow Cyt
Use 0.5µg for 106 cells.

ab170191 - Mouse monoclonal IgG2a, is suitable for use as an isotype control with this antibody.

 
ICC/IF
Use at an assay dependent concentration.

ターゲット情報

  • 関連性

    The gene for CDK2NA generates several transcripts/proteins which differ from each other in their first exons. Three of these transcripts are generated by alternative splicing (isoform 1 a.k.a p16INK4A, isoform 2 and isoform 3 a.k.a p12), two of which are known to function as inhibitors of CDK4 kinase. One other transcript that is generated from this gene contains an alternate reading frame (ARF), with the first exon located 20kb upstream of the remainder of the gene(isoform 4 a.k.a. p14ARF, p19ARF, ARF). In spite of the structural and some functional differences, all the proteins encoded by the CDKN2A gene are involved in cell cycle G1 control.

  • 細胞内局在

    Cytoplasmic and Nuclear

  • 参照データベース

    • 別名

      • ARF antibody
      • CDK4 inhibitor p16 INK4 antibody
      • CDK4I antibody
      • CDKN2 antibody
      • CDKN2A antibody
      • Cell cycle negative regulator beta antibody
      • CMM2 antibody
      • Cyclin dependent kinase 4 inhibitor A antibody
      • Cyclin dependent kinase inhibitor 2A antibody
      • INK4 antibody
      • INK4a antibody
      • Melanoma p16 inhibits CDK4 antibody
      • MLM antibody
      • MTS 1 antibody
      • MTS1 antibody
      • Multiple tumor suppressor 1 antibody
      • p14 antibody
      • p16 antibody
      • p16 INK4a antibody
      • p16INK4a antibody
      • p19 antibody
      • P19ARF antibody
      • TP16 antibody
      see all

    画像

    • Immunocytochemistry/ Immunofluorescence - Anti-CDKN2A/p14ARF antibody [ARF 4C6/4] (ab11048)
      Immunocytochemistry/ Immunofluorescence - Anti-CDKN2A/p14ARF antibody [ARF 4C6/4] (ab11048)
      ICC/IF image of ab11048 stained human MCF7 cells. The cells were 4% PFA fixed (10 min) and then incubated in 1% BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab11048, 1 µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue). This antibody also gave a positive IF result in HeLa, Hek293 and HepG2cells.
    • Flow Cytometry - Anti-CDKN2A/p14ARF antibody [ARF 4C6/4] (ab11048)
      Flow Cytometry - Anti-CDKN2A/p14ARF antibody [ARF 4C6/4] (ab11048)
      Overlay histogram showing HeLa cells stained with ab11048 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab11048, 0.5µg/1x106 cells) for 30 min at 22ºC. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22ºC. Isotype control antibody (black line) was mouse IgG2a [ICIGG2A] (ab91361, 1µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.

    参考文献 (6)

    ab11048 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

    ab11048 は 6 報の論文で使用されています。

    • Lee CK  et al. Syk-mediated tyrosine phosphorylation of mule promotes TNF-induced JNK activation and cell death. Oncogene 35:1988-95 (2016). PubMed: 26212014
    • Hamilton G  et al. AKT regulates NPM dependent ARF localization and p53mut stability in tumors. Oncotarget 5:6142-67 (2014). PubMed: 25071014
    • Jeanblanc M  et al. Parallel pathways in RAF-induced senescence and conditions for its reversion. Oncogene 31:3072-85 (2012). PubMed: 22020327
    • Ma H & Pederson T Depletion of the nucleolar protein nucleostemin causes G1 cell cycle arrest via the p53 pathway. Mol Biol Cell 18:2630-5 (2007). WB, ICC/IF ; Human . PubMed: 17494866
    • Clark PA  et al. Multiple interacting domains contribute to p14ARF mediated inhibition of MDM2. Oncogene 21:4498-507 (2002). PubMed: 12085228
    • Llanos S  et al. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. Nat Cell Biol 3:445-52 (2001). PubMed: 11331871

    レビューと Q&A

    Show All レビュー Q&A
    レビューを送る 質問を送る

    1-5 of 5 Abreviews or Q&A

    Question

    According to Abcam dataab11048 And ab6546 have been tested and suiteble to be used in ELISA.
    Since none of the publication references mentioned in the datasheet uses this method I would like to know the ELISA protocol used in the test.

    I thank youin advance for your help.

    Best regards

    Read More
    Answer

    Thank you for contacting us.

    To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below;

    https://www.abcam.com/ps/pdf/protocols/Sandwich%20ELISA.pdf

    https://www.abcam.com/ps/pdf/protocols/Direct%20ELISA%20protocol.pdf

    https://www.abcam.com/ps/pdf/protocols/Direct%20ELISA%20protocol.pdf

    https://www.abcam.com/ps/pdf/protocols/Indirect%20ELISA%20protocol.pdf

    I hope this information is helpful to you. Please do not hesitate to contact us if you need any more advice or information.

    Use our products? Submit an Abreview. Earn rewards!
    https://www.abcam.com/abreviews

    Read More

    Question

    Dear technical support team: This customer has purchased ab11048 (Anti-CDKN2A/p14ARF antibody [ARF 4C6/4]), and he raised an enquiry about his ICC data which was staining in cell nucleus. However, according to the online reference indicated this protein should expression in cell nucleolar. Therefore, this customer would like to ask for your help to offer some suggestion to him. I also attached his ICC data in this letter, and his experiment step as follow:   1) Order details: ˙Batch number ( Lot number): GR37995-1 ˙Abcam product code: ab11048 ˙Antibody storage conditions (temperature/reconstitution etc) :-20℃ 2) Please describe the problem (high background, non-specific signal…etc). The signal should in nucleolar 3) On what material are you testing the antibody in IHC/ICC? ˙Species: human ˙What’s cell line or tissue: U2OS cell 4) Sample preparation: ˙Type of sample (Fresh frozen sections, perfusion fixed frozen sections, PFA/formalin fixed ˙paraffin embedded sections, cells in culture, other:____) : cell culture ˙Sample preparation: cells seed in coverslip 5) Fixation step ˙Yes or No : yes ˙If yes, Fixative agent and concentration: 4% paraformaldehyde ˙Fixation time: 10min ˙Fixation temperature : room templature 6) Antigen retrieval method(including time, temperature etc.): no   7) Permeabilization method: ˙Permeabilizing agent and concentration: 0.5% Triton X-100 in PBS 8) Blocking agent (eg BSA, serum…): no blocking 9) ˙Endogenous peroxidases blocked? no ˙Endogenous biotins blocked? no 10) Primary antibody (If more than one was used, describe in “additional notes”) : ˙Species: mouse monoclonal ˙Reacts against: p14ARF ˙At what dilution(s) have you tested this antibody: 1:25 ˙Diluent buffer:  PBS ˙Incubation time: overnight ˙Incubation temperature: 4℃ ˙What washing steps were done (which buffer, number of washes): PBS wash three times 11)  Secondary antibody: ˙Species:goat ˙Reacts against which species: mouse ˙At what dilution(s) have you tested this antibody: 1:100 ˙Diluent buffer:PBS ˙Incubation time:1 hour in RT ˙What washing steps were done (which buffer, number of washes): PBS wash three times ˙Fluorochrome or enzyme conjugate (eg: FITC, HRP, AP, biotin…etc):FITC ˙Do you know whether the problems you are experiencing come from the secondary? The secondary antibody is working in other experiment 12) Signal amplification method (eg: ABC, LSAB, HRP polymer, TSE): no 13) Detection method (eg: DAB, BCIP/NBT …etc): no 14) ˙ How many times have you run this staining? Three times ˙Do you obtain the same results every time?  Yes ˙What steps have you altered to try and optimize the use of this antibody? 1. Fixation buffer(paraformaldehyde, formaldehyde or acetone) 2. incubation condition of first antibody   Could you please help this customer to solve the problem? Thanks for your kindly help Best regards

    Read More
    Answer

    Thank you for contacting Abcam Technical Team and for taking the time to provide some useful details of the experiments. I am very sorry to hear that your customer is having problems with this product. According to Swiss-Prot, the localization of the staining (CDKN2A/p14ARF) could be both cytoplasmic and nuclear. You may wish to take a look at this site for further information: http://www.uniprot.org/uniprot/P42771 U2OS is a human osteosarcoma cell line; it is known that CDKN2A/p14ARF is widely expressed but not detected in certain tissue such brain or skeletal muscle. There are at least 4 different splice variants and the expression pattern of these isoforms (P42771-1, P42771-2, P42771-3, Q8N726-1) may vary in different tissue/cell types. After reading through the detailed protocol you kindly forwarded to Abcam, I would like to make the following comments/suggestions: 1) Try to use cells which are intensively dividing and the cell culture should in exponential (log) phase of growth. 2) It may be worth staining HeLa cells or sections of human liver or lymphomas as good positive control. 3) In order to increase the signal, it would be worth applying ABC signal enhancing system. I hope this helps and if I can assist further, please do not hesitate to contact me.

    Read More

    Question

    Has ab11048 been tetsed in Western blot to detect endogenous p14ARF?

    Read More
    Answer

    Thank you for your enquiry. Our source for this antibody has told me that ab11048 does detect endogenous p14ARF; please see the following publication for additional information: Llanos S et al. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. Nat Cell Biol 3:445-52 (2001). PubMed: 11331871 If you have any additional questions, please contact us again.

    Read More

    Question

    Thanks a lot. I did a PubMed search for "HeLa cells and ARF", and found a paper, which shows the band detected by the same antibody as that I obtained from your company. I am looking for some HeLa cells, hopefully to get some positive control samples. Have a nice weekend. Oncogene. 2002 Oct 3;21(44):6779-90. Human p14(Arf): an exquisite sensor of morphological changes and of short-lived perturbations in cell cycle and in nucleolar function. David-Pfeuty T, Nouvian-Dooghe Y. UMR 146 du CNRS, Institut Curie-Recherche, Batiment 110, Centre Universitaire, 91405 Orsay Cedex, France. Therese.Pfeuty@curie.u-psud.fr The human Ink4a/Arf tumor suppressor locus encodes two distinct products: p16(Ink4a) which prevents phosphorylation and inactivation of the retinoblastoma protein and, p14(Arf), a nucleolar protein which activates the function of the tumor suppressor p53 protein in the nucleoplasm in response to oncogenic stimulation through an as yet ill-defined mechanism. Here we show that the level of endogenous p14(Arf) and its balance between the nucleolus and the nucleoplasm in HeLa cells are exquisitely sensitive to changes in cell morphology and to short-lived perturbations in cell cycle and in nucleolar function such as those induced by the cyclin-dependent kinase inhibitor, roscovitine, and the casein kinase II and RNA synthesis inhibitor, DRB. Most remarkably, whereas p14(Arf) predominantly concentrates in the nucleolus of interphase cells and transiently disappears between metaphase and early G1 under normal growth conditions, it massively and reversibly accumulates in the nucleoplasm of postmitotic and S-phase cells upon short-term treatment with roscovitine and, at a lesser extent, DRB. In line with the fact that the nuclear level of p53 reaches a peak between mid-G1 and the G1/S border in p53-expressor cells which lack Arf expression, these results provide a clue that, in p53+/Arf+ cells, Arf proteins might serve both to speed and to amplify p53-mediated responses in conditions and cell cycle periods in which the mechanisms involved in p53 stabilization and activation are not fully operational. They further suggest that human endogenous p14(Arf) might activate p53 pathways in physiologic situations by acting inside the nucleoplasm, especially when normal cell cycle progression and nucleolar function are compromised.

    Read More
    Answer

    Thank you for the information about the paper, if you have any more questions, just let us know.

    Read More

    Question

    Please find the image of the x-ray film in the attached files.

    Read More
    Answer

    Thank you for your enquiry. Although I was unable to find out exactly what the originator used as a positive control, they have said that Hela cells should be appropriate to use as a positive control for this antibody. If you have any more questions, please contact me again.

    Read More

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
    For licensing inquiries, please contact partnerships@abcam.com